oral semaglutide cardiovascular outcomes soul trial results 2024 2025 nejm Oral Semaglutide's Impact on Cardiovascular Events in Type 2 Diabetes Patients with Cardiovascular and Kidney Disease: SOUL Trial Results Semaglutide reduces heart failure risk

"FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss"

Limit when symptoms flare: Deep fried or greasy foods (often worsen nausea and reflux) Very spicy foods (can irritate reflux and nausea) High-sugar drinks and sweets (low satiety, can spike glucose) Alcohol (can worsen dehydration and GI upset

Researchers in this study analyzed electronic records of nearly 33,000 patients with OUD and who were prescribed diabetes medications between December 2017 and June 2023

The primary concern is increased gastrointestinal discomfort or irritation, as both medications can affect the digestive system

Visiting Professor: Anaplastic, Medullary, and Biologically Aggressive Differentiated Thyroid Cancer: Integration of Systemic Therapy with Surgery

The 0.9% standard represents the established balance that the research community relies on, and medical-grade manufacturing ensures precise formulation